NEW YORK, NY — As Breast Cancer Awareness Month blankets the world in pink ribbons each October, a critical reality often slips through the cracks of the broader conversation. While the public is frequently inundated with messages regarding early detection and the "cure" for localized breast cancer, a stark, terminal shadow remains for those living with Stage 4 metastatic breast cancer (MBC).
On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor Research and Support will once again push this reality into the light. Through their flagship global initiative, #LightUpMBC, more than 325 landmarks across all 50 U.S. states, 20 countries, and 195 cities will illuminate in the movement’s signature colors—teal, green, and pink—to demand attention, honor those lost, and catalyze funding for the only research that can change the trajectory of the disease.
The Reality of Stage 4: More Than Just a Diagnosis
To understand the urgency of #LightUpMBC, one must first confront the medical reality of metastatic breast cancer. MBC occurs when breast cancer cells migrate from the original site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. Crucially, it remains breast cancer regardless of where it travels; a lung tumor originating from breast cancer is not lung cancer, but metastatic breast cancer.
For some patients, the diagnosis comes as a shock—they are classified as Stage 4 from their very first visit to the doctor. For others, the disease emerges months, years, or even decades after the successful treatment of an early-stage diagnosis.
The clinical landscape is equally grueling. For those living with MBC, there is no "finish line." Treatment is a perpetual cycle; even when clinical scans show "no evidence of disease" (NED), it does not mean the patient is cured. It simply means the disease is currently suppressed. Because cancer cells eventually develop resistance to therapies, patients must navigate a revolving door of treatments, constantly searching for the next intervention to extend their lives while maintaining the best possible quality of life.
With an estimated 42,670 people in the United States projected to die from breast cancer in 2026—roughly 117 lives lost every single day—the need for transformative research has never been more acute.
A Chronology of Advocacy: From a Single Light to a Global Movement
The #LightUpMBC movement was born not from corporate strategy, but from profound personal loss and a singular vision. In 2017, the movement began in New Hampshire, when the Memorial Bridge was illuminated to honor those fighting the disease.
The initiative was championed by Laura Inahara, who was inspired by her best friend, Jessica Moore. Moore, who was diagnosed with MBC at a young age, had a simple, poignant wish: to see a local landmark lit up to represent the often-ignored community of Stage 4 patients. Though Moore passed away at the age of 36, her legacy ignited a wildfire of activism.
What began as a localized effort to "shine a light" on a hidden disease has grown exponentially over the last nine years. By 2026, the campaign has evolved into a sophisticated global event, connecting families, scientists, and advocates across international borders. The growth of the movement mirrors the growing public awareness that while early detection saves lives, it does not solve the terminal nature of metastatic disease.
Supporting Data: Why Research is the Only Path Forward
The financial reality of breast cancer research often highlights a systemic disparity. While billions are spent annually on breast cancer, only a small fraction of those funds is specifically earmarked for metastatic research. METAvivor exists to bridge this gap. As the only organization that exclusively funds Stage 4 research, they utilize a rigorous, two-tiered review process. Every grant proposal undergoes both a scientific peer review and a patient advocate review, ensuring that the research not only holds academic merit but also directly addresses the needs and quality-of-life concerns of the people living with the disease.
The impact of this funding is tangible. To date, the #LightUpMBC campaign has raised over $2.7 million, directly fueling high-impact projects that aim to transform MBC from a terminal diagnosis into a manageable, chronic, and eventually curable condition.
Voices from the Frontlines: Official Perspectives
The leadership behind METAvivor is comprised of those who understand the stakes intimately. Dr. Kelly Shanahan, the organization’s Board President, is a living testament to the necessity of their mission.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
This sentiment is echoed by the campaign’s founder, Laura Inahara, who views the annual illumination as a bridge between the physical and the digital worlds. "Jessica hoped to illuminate one local landmark," Inahara stated. "Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
The Centerpiece: #LightUpMBC Live
The pinnacle of the October 13 awareness campaign is the #LightUpMBC Live broadcast. Airing at 8 p.m. ET / 5 p.m. PT, the event is designed to be both an educational experience and a celebration of life.
Hosted by Tami Eagle Bowling, who has lived with MBC for 11 years, and Broadway performer and breast cancer survivor Kara Lindsay, the livestream serves as a digital town hall for the global MBC community. The program promises a mix of:
- Patient Perspectives: Live stories shared from illuminated landmarks around the world.
- Scientific Insight: Expert commentary on the latest breakthroughs in Stage 4 treatment.
- Artistic Expression: Musical performances from industry heavyweights, including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, and singer-songwriter Cassandra Kubinski.
The broadcast will be available for free on the METAvivor YouTube channel, Facebook Live, and through the LiveOne streaming platform.
Implications: Changing the Future of Oncology
The success of #LightUpMBC carries significant implications for the future of cancer treatment and social advocacy. By focusing on the "invisible" terminal patients, the campaign challenges the narrative that breast cancer is a "solved" problem. It forces policymakers, pharmaceutical companies, and the public to confront the fact that current standard-of-care treatments are not enough.
Furthermore, the campaign empowers patients to become active participants in their own care. By providing a platform for patient voices, METAvivor is shifting the culture of oncology, moving away from a model where patients are passive recipients of treatment toward one where they are partners in the scientific process.
As landmarks like One World Trade Center, the Willis Tower, and Niagara Falls turn teal, green, and pink, the message to the world is clear: The light is not just for remembrance—it is for progress. Every dollar raised through this campaign is a dollar directed toward the laboratory, where the next generation of therapies will be born.
For those wishing to join the movement, the call to action is simple. The public is encouraged to photograph participating landmarks, share them on social media using the hashtags #LightUpMBC and #METAvivor, and engage with the live stream. In doing so, they become part of a global, glowing network that refuses to let those living with metastatic breast cancer be left in the dark.
For more information, to find a list of participating landmarks, or to donate to the cause, visit www.lightupmbc.org.
About the Author
